Nine of the ten metabolites including MCNP, MCOP, MECPP, MBP, MCPP, MEHHP, MiBP, MEOHP, and MBzP were generally correlated with modest reduction in systolic/diastolic BP and MAP, but not associated with decreased risks of hypertension. This evidence concerns the gene NMRK2 and hypertensive disorder.